Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001077183-21-000256)

Filing Details

Accession Number:: 0001077183-21-000256
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-06 16:16:42
Reporting Period:: 2021-12-06

Accepted Time:: 2021-12-06 16:16:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1077183	Neogenomics Inc	NEO	Services-Testing Laboratories (8734)	742897368

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1763533	Mark Mallon	9490 Neogenomics Way Fort Myers FL 33912	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-12-06	17,000	$30.63	72,736	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$49.34		2028-04-19	151,016	151,016	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2028-04-19	151,016	151,016	Direct

Footnotes

On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date.